Count | |
| 4 | |
| 1 | |
| 7 | |
| 8 | |
| 6 | |
| 1 | |
| 1 | |
| 3 | |
| 22 | |
Cyclophosphamide/adverse effects/*analogs & derivatives/pharmacology | 1 |
| 93 | |
| 28 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 2 | |
| 4 | |
| 3 | |
| 1 | |
| 2 | |
| 9 | |
Cyclophosphamide/*analogs & derivatives/pharmacology/therapeutic use | 1 |
Cyclophosphamide/administration & dosage/*therapeutic use/toxicity | 1 |
Cyclophosphamide/cerebrospinal fluid/*pharmacokinetics/therapeutic use | 1 |
Cyclophosphamide/administration & dosage/metabolism/*therapeutic use | 1 |
Cyclophosphamide/administration & dosage/immunology/*therapeutic use | 1 |
Cyclophosphamide/administration & dosage/*pharmacology/therapeutic use | 1 |
Cyclophosphamide/analogs & derivatives/pharmacology/therapeutic use | 1 |
| 1 | |
| 3 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 2 | |
| 2 | |
| 3 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 2 | |
| 1 | |
| 1 | |
| 2 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 3 | |
| 1 | |
| 1 | |
| 1 | |
| 2 | |
| 11 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 9 | |
| 2 | |
| 1 | |
| 1 | |
| 1 | |
| 5 | |
| 1 | |
| 3 | |
| 1 | |
| 2 | |
| 2 | |
| 2 | |
| 1 | |
| 4 | |
| 1 | |
| 1 | |
| 1 | |
| 2 | |
| 1 | |
| 1 | |
| 3 | |
| 1 | |
| 1 | |
| 1 | |
| 2 | |
| 2 | |
| 1 | |
| 1 | |
| 16 | |
| 1 | |
| 1 | |
| 5 | |
| 1 | |
| 1 | |